Monte Rosa Therapeutics, Inc. (GLUE)
17.25
+0.26
(+1.53%)
USD |
NASDAQ |
Dec 10, 15:35
Monte Rosa Therapeutics Market Cap: 1.123B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 252.11B |
| AVITA Medical, Inc. | 107.64M |
| NanoVibronix, Inc. | 4.755M |
| Mirum Pharmaceuticals, Inc. | 3.296B |
| Day One Biopharmaceuticals, Inc. | 888.14M |
Market Cap Related Metrics
| PE Ratio | 56.48 |
| PS Ratio | 7.342 |
| Price to Book Value | 4.569 |
| Price to Free Cash Flow | 9.190 |
| Price | 17.25 |
| Earnings Yield | 1.77% |
| Operating PE Ratio | 156.59 |
| Normalized PE Ratio | 56.48 |